2576.HK Stock - Zhejiang Taimei Medical Technology Co., Ltd.
Unlock GoAI Insights for 2576.HK
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $551.16M | $573.14M | $549.22M | $466.18M |
| Gross Profit | $224.94M | $179.00M | $185.40M | $163.59M |
| Gross Margin | 40.8% | 31.2% | 33.8% | 35.1% |
| Operating Income | $-252,452,000 | $-396,587,000 | $-442,784,000 | $-505,634,000 |
| Net Income | $-214,609,000 | $-346,778,000 | $-412,907,000 | $-479,611,000 |
| Net Margin | -38.9% | -60.5% | -75.2% | -102.9% |
| EPS | $-0.39 | $-0.62 | $-0.74 | $-0.86 |
Zhejiang Taimei Medical Technology Co., Ltd. provides digital operation platform for the biopharma industry in China. The company offers TrialOS, a drug digital cooperation platform that connects the cycle of hospitals, pharmaceutical companies, third-party providers, regulatory authorities, patients, and other industry stakeholders. It offers software solutions, such as eCooperate, a clinical trial cooperation platform that optimizes clinical research operations management systems, as well as support decision-making with big data technology; eArchives, a clinical trial master file system; eCollect, an electronic data capture system; eCollege, a training management system; eQuality, an electronic quality audit system; eBalance, an interactive Web-based response system; eVisit Patient Reported Outcomes, a solution that enhances the ability of patients to enter data and the accuracy of clinical trial data; eTime, a project man-hour management system; and eImage, a medical image reading system. It also provides hospital software, including eTrial, a phase I ward management system; eSite, a clinical trial management system for GCP sites; GCP-X, an intelligent clinical trial platform; NomenCTMS, a clinical research project management system for GCP sites; eScreening, a subject information management and duplicate checking system; Intelligent Investigator, an initiated clinical trial platform; IIT-EDC, a clinical research data management platform; and Investigator-Initiated Clinical Trial Management System, a project management system. In addition, the company offers pharmacovigilance software solutions, such as eSafety global pharmacovigilance system; eSafety, an intelligent professional information system for pharmacovigilance; and SAE Manager, a safety data communication and management system for clinical trials. Further, it provides marketing software and digital innovation solutions. The company was founded in 2013 and is headquartered in Jiaxing, China.
Visit WebsiteEarnings History & Surprises
2576.HKEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Aug 28, 2025 | — | $-0.04 | — | — |
Latest News
Frequently Asked Questions about 2576.HK
What is 2576.HK's current stock price?
What is the analyst price target for 2576.HK?
What sector is Zhejiang Taimei Medical Technology Co., Ltd. in?
What is 2576.HK's market cap?
Does 2576.HK pay dividends?
Similar Stocks
Technology SectorExplore stocks similar to 2576.HK for comparison